All In Biotech

Drug Trial Radar · NCT04945018

A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)

A Phase I/II Study of Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Severe Heart Failure, Secondary to Ischemic Heart Disease

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Apr 19, 2022

Primary completion

Jul 31, 2025

Study completion Jan 31, 2026

Sponsor

Lead sponsor
Heartseed Inc.Industry
Sponsor type
Industry
First posted
Jun 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to evaluate the safety and efficacy of HS-001 CS transplanted into severe heart failure patients with underlying ischemic heart disease for 26 weeks after transplantation.

Conditions

  • Heart Failure
  • Ischemic Heart Disease

Interventions

  • HS-001 CSBiological

    Human (allogeneic) iPS-cell-derived cardiomyocyte spheroids suspension

  • HS-001-D needle, HS-001-D AdaptorDevice

    Cardiomyocyte spheroids Dedicated Needles for Implantation and Guided Adaptors

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: 26 weeks post-transplant

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • St. Marianna University Hospital

    Kawasaki, Japan

  • Saitama Medical University International Medical Center

    Saitama, Japan

  • Juntendo University Hospital

    Tokyo, Japan

  • Nihon University Itabashi Hospital

    Tokyo, Japan

  • The University of Tokyo Hospital

    Tokyo, Japan

  • Tokyo Medical and Dental University Medical Hospital

    Tokyo, Japan

  • Tokyo Metropolitan Geriatric Medical Center

    Tokyo, Japan

  • Tokyo Women's Medical University

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.